In breast cancer, stiff matrix is found to be associated with poor survival and tumor aggressiveness [87], probably due to the activation of MYC and the suppression of phosphatase and tensin homolog (PTEN) and homeobox A9 (HOXA9) [88]. This evidence concerns the gene HOXA9 and breast cancer.